Stem cells industry and beyond: What is the aftermath of Brüstle?

European Journal of Risk Regulation

Volumn 3, Issue 1, 2012, Pages 93-97

  Bonadio, Enrico ^a  

^a CITY UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880961606     PISSN: 1867299X     EISSN: 21908249     Source Type: Journal    
DOI: 10.1017/S1867299X00001860     Document Type: Article

References (4)

1. For a brief technical overview of HESCs and the associated ethical concerns see Kenneth C. Cheney, "Patentability of Stem Cell Research under TRIPS: Can Morality-Based Exclusions be Better Defined by Emerging Customary International Law?", 29 Loyola of Los Angeles International and Comparative Law Review (2007), pp. 505 et sqq.
2. Antonina Bakardjieva, "Stem Cells Patenting and Competition Law", in Aurora Plomer and Paul Torremans (eds.), Embryonic Stem Cell Patents (Oxford: Oxford University Press, 2009), p. 372.
3. Peter Van Den Bossche, The Law and Policy of the World Trade Organization: Text, Cases and Materials, (Cambridge: Cambridge University Press, 2008), p. 785.
4. Dan Leskien and Michael Flitner, "Intellectual Property Rights and Plant Genetic Resources: Options for a Sui Generis System", IPGRI, Issues in Genetic Resources No. 6, 1997, p. 15, available on the Internet at (last accessed on 4 January 2012).